Brain Cancer Trial, Recruiting NCT07216157 Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT07216157
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who are already scheduled to have a type of nasal/sinus surgery (endoscopic endonasal surgery) that involves a standard repair of the base of the skull
  • People who have given written consent to participate before the study begins
  • People whose blood pressure and body chemistry (such as salt levels) are stable before surgery
  • People whose surgery is not expected to require special techniques to divert fluid from around the brain during the procedure

Who may not be able to join:

  • People having a repeat surgery, or a more complex surgery that requires a difficult reconstruction of certain skull base areas (confirm with trial site)
  • People whose tumour requires a complex repair of the pituitary area (sella) from the beginning of surgery
  • People who have a build-up of fluid on the brain (hydrocephalus) before surgery
  • People who have a known allergy to fibrin-based (derived from blood proteins) or synthetic sealant materials used in surgery
  • People who have an active sinus infection or a widespread inflammatory condition in their body
  • People who have previously had radiation treatment to the area around the pituitary gland at the base of the brain
  • People with poorly controlled diabetes (where a specific blood sugar marker called HbA1c is above 7.0%)
  • People who are already taking part in another clinical trial that could affect wound healing or the assessment of fluid around the brain
  • People whose brain scans show signs of long-term abnormally high or abnormally low pressure inside the skull

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +48788599550

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Maria Sklodowska-Curie National Research Institute of Oncology
Registry
ClinicalTrials.gov
Start date
15 August 2025
Est. completion
30 December 2026

Where this trial is recruiting

🇵🇱 Poland

Primary endpoints

Incidence of postoperative cerebrospinal fluid (CSF) leak within 90 days

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov